These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 26546412

  • 1. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
    Tso JL, Yang S, Menjivar JC, Yamada K, Zhang Y, Hong I, Bui Y, Stream A, McBride WH, Liau LM, Nelson SF, Cloughesy TF, Yong WH, Lai A, Tso CL.
    Mol Cancer; 2015 Nov 06; 14():189. PubMed ID: 26546412
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.
    Perazzoli G, Prados J, Ortiz R, Caba O, Cabeza L, Berdasco M, Gónzalez B, Melguizo C.
    PLoS One; 2015 Nov 06; 10(10):e0140131. PubMed ID: 26447477
    [Abstract] [Full Text] [Related]

  • 4. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
    Miao W, Liu X, Wang H, Fan Y, Lian S, Yang X, Wang X, Guo G, Li Q, Wang S.
    Mol Med Rep; 2015 Jun 06; 11(6):4165-73. PubMed ID: 25625235
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.
    Tentori L, Ricci-Vitiani L, Muzi A, Ciccarone F, Pelacchi F, Calabrese R, Runci D, Pallini R, Caiafa P, Graziani G.
    BMC Cancer; 2014 Mar 05; 14():151. PubMed ID: 24593254
    [Abstract] [Full Text] [Related]

  • 6. Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression.
    Zhao Y, Xiao Z, Chen W, Yang J, Li T, Fan B.
    Mol Med Rep; 2015 Aug 05; 12(2):2313-22. PubMed ID: 25937029
    [Abstract] [Full Text] [Related]

  • 7. The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity.
    Remington M, Chtchetinin J, Ancheta K, Nghiemphu PL, Cloughesy T, Lai A.
    Neuro Oncol; 2009 Feb 05; 11(1):22-32. PubMed ID: 18812520
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells.
    Happold C, Roth P, Wick W, Schmidt N, Florea AM, Silginer M, Reifenberger G, Weller M.
    J Neurochem; 2012 Jul 05; 122(2):444-55. PubMed ID: 22564186
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
    Okada M, Sato A, Shibuya K, Watanabe E, Seino S, Suzuki S, Seino M, Narita Y, Shibui S, Kayama T, Kitanaka C.
    Int J Oncol; 2014 Feb 05; 44(2):591-9. PubMed ID: 24316756
    [Abstract] [Full Text] [Related]

  • 13. Effect of O6-Substituted Guanine Analogs on O6-methylguanine DNA-methyltransferase Expression and Glioblastoma Cells Viability.
    St-Coeur PD, Cormier M, LeBlanc VC, Morin PJ, Touaibia M.
    Med Chem; 2016 Feb 05; 13(1):28-39. PubMed ID: 27396904
    [Abstract] [Full Text] [Related]

  • 14. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma.
    Wu S, Li X, Gao F, de Groot JF, Koul D, Yung WKA.
    Neuro Oncol; 2021 Jun 01; 23(6):920-931. PubMed ID: 33433610
    [Abstract] [Full Text] [Related]

  • 15. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
    Balvers RK, Lamfers ML, Kloezeman JJ, Kleijn A, Berghauser Pont LM, Dirven CM, Leenstra S.
    J Transl Med; 2015 Feb 26; 13():74. PubMed ID: 25886061
    [Abstract] [Full Text] [Related]

  • 16. MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis.
    Sato A, Sunayama J, Matsuda K, Seino S, Suzuki K, Watanabe E, Tachibana K, Tomiyama A, Kayama T, Kitanaka C.
    Stem Cells; 2011 Dec 26; 29(12):1942-51. PubMed ID: 21957016
    [Abstract] [Full Text] [Related]

  • 17. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
    Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, Roos W, Kaina B, Weller M.
    J Neurochem; 2006 Feb 26; 96(3):766-76. PubMed ID: 16405512
    [Abstract] [Full Text] [Related]

  • 18. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
    Kokkinakis DM, Ahmed MM, Chendil D, Moschel RC, Pegg AE.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3801-7. PubMed ID: 14506174
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.